A Systematic Review of the Pulmonary Microbiome in Patients with Acute Exacerbation COPD Requiring ICU Admission

Sjoerd van der Bie,Mark E. Haaksma,Ben Vermin,Hidde van Assema,Eric C. M. van Gorp,Thomas Langerak,Henrik Endeman,Dominic Snijders,Johannes P. C. van den Akker,Marlies A. van Houten,Steven F. L. van Lelyveld,Marco Goeijenbier
DOI: https://doi.org/10.3390/jcm13020472
IF: 3.9
2024-01-16
Journal of Clinical Medicine
Abstract:Background: Chronic obstructive pulmonary disease (COPD) is a major health concern. Acute exacerbations (AECOPD) may require intensive care unit (ICU) admission and mechanical ventilation. Acute infections and chronic colonization of the respiratory system are known to precipitate AECOPD. Detailed knowledge of the respiratory microbiome could lead to effective treatment and prevention of exacerbations. Objective: The aim of this review is to summarize the available evidence on the respiratory microbiome of patients with a severe AECOPD requiring mechanical ventilation and intensive care admission. Methods: A systematic literature search was conducted to identify the published papers until January 2023. The collected data were then subjected to qualitative analysis. After the first analysis, a secondary focused review of the most recent publications studying the relationship between microbiome and mortality in AECOPD was performed. Results: Out of 120 screened articles six articles were included in this review. Potentially pathogenic microorganisms (PPMs) were identified in 30% to 72% of the patients with community-acquired bacteria, gram-negative enteric bacilli, Stenotrophomonas and Pseudomonas being the most frequently isolated. During hospitalization, 21% of patients experienced colonization by PPMs. Adequate antimicrobial therapy resulted in the eradication of 77% of the identified PPMs. However, 24% of the bacteria displayed multi-drug resistance leading to prolonged or failure of eradication. Conclusion: PPMs are prevalent in a significant proportion of patients experiencing an AECOPD. The most identified PPMs include community-acquired pathogens and gram-negative enteric bacilli. Notably, no differences in mortality or duration of ventilation were observed between patients with and without isolated PPMs. However, the included studies did not investigate the virome of the patients, which may influence the microbiome and the outcome of infection. Therefore, further research is essential to comprehensively investigate the complete microbial and viral composition of the lower respiratory system in COPD patients admitted to the ICU.
medicine, general & internal
What problem does this paper attempt to address?
### Problems the Paper Attempts to Solve This paper aims to summarize the relevant evidence on the respiratory microbiome of patients in the intensive care unit (ICU) who require mechanical ventilation due to acute exacerbations of chronic obstructive pulmonary disease (AECOPD). #### Research Background - **COPD is a significant health issue**: COPD is the third leading cause of death globally. - **Acute exacerbations (AECOPD)**: May lead to the need for ICU admission and mechanical ventilation. - **Respiratory infections**: Acute or chronic respiratory infections are important factors leading to AECOPD. - **Respiratory microbiome**: Further understanding of the respiratory microbiome may help in the effective treatment and prevention of AECOPD. #### Research Objectives - **Systematic literature review**: Summarize the respiratory microbiome data of severe AECOPD patients requiring mechanical ventilation. - **Methods**: A systematic literature search was conducted to identify relevant studies published up to January 2023, and the collected data were qualitatively analyzed. #### Main Findings - **Potential pathogenic microorganisms (PPMs)**: PPMs were detected in 30% to 72% of patients, including community-acquired bacteria, Gram-negative enterobacteria, Pseudomonas aeruginosa, etc. - **Colonization during hospitalization**: 21% of patients developed PPMs colonization during hospitalization. - **Effectiveness of antimicrobial treatment**: After appropriate antimicrobial treatment, 77% of PPMs were cleared. However, 24% of bacteria exhibited multidrug resistance, leading to treatment failure. - **Clinical outcomes**: The presence of PPMs was not significantly associated with mortality or the duration of mechanical ventilation. However, the mortality rate was significantly higher in patients with multidrug-resistant (MDR) infections. #### Conclusion - **PPMs are prevalent in AECOPD patients**, with the most common being community-acquired pathogens and Gram-negative enterobacteria. - **No observed impact of PPMs on mortality or mechanical ventilation duration**. - **Viral microbiome not studied**: The viral microbiome may affect the microbiome and infection outcomes, thus further research is needed to fully understand the lower respiratory tract microbiome and virome in COPD patients. Through these findings, the paper emphasizes the importance of further research on the respiratory microbiome of severe AECOPD patients and its relationship with clinical outcomes.